Rankings
▼
Calendar
GHRS
GH Research PLC
$1B
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$2M
EPS (Diluted)
$-0.05
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$12,000
Balance Sheet
Total Assets
$293M
Total Liabilities
$5M
Stockholders' Equity
$288M
Cash & Equivalents
$293M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$3M
-$42,000
-6264.3%
Net Income
-$2M
-$42,000
-4959.5%
← FY 2021
All Quarters
Q3 2021 →
GHRS Q2 2021 Earnings — GH Research PLC Revenue & Financial Results | Market Cap Arena